Results 101 to 110 of about 67,243 (240)

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer

open access: yesPathology and Oncology Research
Pancreatic adenocarcinoma is one of the deadliest forms of cancer with no effective therapeutic options. A KRAS mutation can be found in up to 90% of all pancreatic tumors, making it a promising therapeutic target. The introduction of new KRAS inhibitors
Eszter Molnár   +11 more
doaj   +1 more source

Dental workforce 2012 [PDF]

open access: yes
Summary: Access to reliable, comprehensive, timely and nationally consistent trend data is required to understand the current health workforce and for its future planning. There is particular interest in changes to the size and composition of the various
Ian Titulaer   +2 more
core  

Correction: Fatal stray dog attack in Russian federation: a case report based on CCTV Documentation. [PDF]

open access: yesForensic Sci Med Pathol
Zolotenkova G   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy